Development of a high-purified type of phospholipids to be used in the production of the light carrier media, medical devices and supplements (Q84131): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: summary (P836): The project involves carrying out industrial research and development work on the development of cleaning technologies for the purification of lecithins for the purpose of obtaining pure phospholipid fraction for innovative pharmaceutical technologies, followed by the implementation of the results of the work by mobilising the production of high quality raw material for the production of solid carriers.The project will result in a composition...) |
(Created claim: summary (P836): The project involves carrying out industrial research and development work on the development of lecithin purification technology in order to obtain a pure phospholipid fraction for use in innovative pharmaceutical technologies, and then implement the results by launching the production of high-quality raw material necessary for the production of liposomal drugs carriers. As a result of the project, the composition of the innovative product (opt...) |
||||||||||||||
| Property / summary | |||||||||||||||
The project involves carrying out industrial research and development work on the development of lecithin purification technology in order to obtain a pure phospholipid fraction for use in innovative pharmaceutical technologies, and then implement the results by launching the production of high-quality raw material necessary for the production of liposomal drugs carriers. As a result of the project, the composition of the innovative product (optimal composition of hydrophilic parts of phospholipids, alkyl chains and non-phospholipid fractions) and the way in which it is obtained will be developed. The main objective of the project is to create and implement effective solutions that are an innovation on a global scale in the field of phospholipids, with optimal parameters for the creation of nanoagregates for the directed supply of medicines, supplements and medical devices. Specific objectives: development of an innovative composition and method of production of phospholipids guaranteeing nanostructures, including low-energy emergency processes; the identification of key lecithin parameters determining the stability of nano-aggregates will be investigated primarily for rape-lacytin, which is ideal for this type of application; introduction of solutions’ not available for competition (development of a unique process of producing lipid aggregates with specified parameters based on the non-genetically modified rapeseed produced in Poland). The project consists of 4 stages of industrial research and 2 stages of development. As a result, the following will be created: phospholipid composition optimal for the production of self-organised lipid structures with specified parameters development of a method of purification of lecithins for obtaining phospholipids optimal for liposome formation; determination of toxicity and efficacy profiles (English) | |||||||||||||||
| Property / summary: The project involves carrying out industrial research and development work on the development of lecithin purification technology in order to obtain a pure phospholipid fraction for use in innovative pharmaceutical technologies, and then implement the results by launching the production of high-quality raw material necessary for the production of liposomal drugs carriers. As a result of the project, the composition of the innovative product (optimal composition of hydrophilic parts of phospholipids, alkyl chains and non-phospholipid fractions) and the way in which it is obtained will be developed. The main objective of the project is to create and implement effective solutions that are an innovation on a global scale in the field of phospholipids, with optimal parameters for the creation of nanoagregates for the directed supply of medicines, supplements and medical devices. Specific objectives: development of an innovative composition and method of production of phospholipids guaranteeing nanostructures, including low-energy emergency processes; the identification of key lecithin parameters determining the stability of nano-aggregates will be investigated primarily for rape-lacytin, which is ideal for this type of application; introduction of solutions’ not available for competition (development of a unique process of producing lipid aggregates with specified parameters based on the non-genetically modified rapeseed produced in Poland). The project consists of 4 stages of industrial research and 2 stages of development. As a result, the following will be created: phospholipid composition optimal for the production of self-organised lipid structures with specified parameters development of a method of purification of lecithins for obtaining phospholipids optimal for liposome formation; determination of toxicity and efficacy profiles (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: The project involves carrying out industrial research and development work on the development of lecithin purification technology in order to obtain a pure phospholipid fraction for use in innovative pharmaceutical technologies, and then implement the results by launching the production of high-quality raw material necessary for the production of liposomal drugs carriers. As a result of the project, the composition of the innovative product (optimal composition of hydrophilic parts of phospholipids, alkyl chains and non-phospholipid fractions) and the way in which it is obtained will be developed. The main objective of the project is to create and implement effective solutions that are an innovation on a global scale in the field of phospholipids, with optimal parameters for the creation of nanoagregates for the directed supply of medicines, supplements and medical devices. Specific objectives: development of an innovative composition and method of production of phospholipids guaranteeing nanostructures, including low-energy emergency processes; the identification of key lecithin parameters determining the stability of nano-aggregates will be investigated primarily for rape-lacytin, which is ideal for this type of application; introduction of solutions’ not available for competition (development of a unique process of producing lipid aggregates with specified parameters based on the non-genetically modified rapeseed produced in Poland). The project consists of 4 stages of industrial research and 2 stages of development. As a result, the following will be created: phospholipid composition optimal for the production of self-organised lipid structures with specified parameters development of a method of purification of lecithins for obtaining phospholipids optimal for liposome formation; determination of toxicity and efficacy profiles (English) / qualifier | |||||||||||||||
point in time: 14 October 2020
| |||||||||||||||
Revision as of 14:30, 14 October 2020
Project in Poland financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development of a high-purified type of phospholipids to be used in the production of the light carrier media, medical devices and supplements |
Project in Poland financed by DG Regio |
Statements
4,259,000.0 zloty
0 references
5,008,125.0 zloty
0 references
85.04 percent
0 references
1 October 2018
0 references
31 March 2021
0 references
LIPID SYSTEMS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
0 references
Projekt zakłada przeprowadzenie badań przemysłowych oraz prac rozwojowych nad opracowaniem technologii oczyszczania lecytyn pod kątem uzyskania czystej frakcji fosfolipidowej do zastosowania w innowacyjnych technologiach farmaceutycznych, a następnie wdrożenie wyników prac poprzez uruchomienie produkcji wysokiej jakości surowca niezbędnego w produkcji liposomowych nośników leków. W wyniku realizacji projektu zostanie opracowany skład innowacyjnego wyrobu (optymalny skład hydrofilowych części fosfolipidów, łańcuchów alkilowych oraz frakcji niefosfolipidowej), jak i sposób jego otrzymywania. Celem głównym projektu jest stworzenie i wdrożenie skutecznych rozwiązań będących innowacją na skalę światową w dziedzinie otrzymywania fosfolipidów, o optymalnych parametrach dla tworzenia nanoagregatów dla kierowanego dostarczania leków, suplementów oraz wyrobów medycznych. Cele szczegółowe : opracowanie innowacyjnego składu i sposobu wytwarzania fosfolipidów gwarantujących otrzymywanie nanostruktur, w tym w oparciu o niskoenergetyczne procesy emergencyjne; zidentyfikowanie kluczowych parametrów lecytyn decydujących o stabilności nano-agregatów, badana będzie głównie lacytyna rzepakowa, która doskonale nadaje się do tego typu zastosowań; wprowadzenie rozwiązań´ niedostępnych dla konkurencji (opracowanie unikalnego procesu wytwarzania agregatów lipidowych o zadanych parametrach w oparciu o produkowany w Polsce nie modyfikowany genertcznie rzepak). Na projekt składają się 4 etapy badań przemysłowych i 2 etapy prac rozwojowych. W ich efekcie powstaną: skład fosfolipidów optymalny do otrzymywania samoorganizujących się struktur lipidowych o zadanych parametrach opracowanie metody oczyszczania lecytyn pod kątem uzyskania fosfolipidów optymalnych do tworzenia liposomów ; określenie profili toksyczności oraz skuteczn (Polish)
0 references
The project involves carrying out industrial research and development work on the development of lecithin purification technology in order to obtain a pure phospholipid fraction for use in innovative pharmaceutical technologies, and then implement the results by launching the production of high-quality raw material necessary for the production of liposomal drugs carriers. As a result of the project, the composition of the innovative product (optimal composition of hydrophilic parts of phospholipids, alkyl chains and non-phospholipid fractions) and the way in which it is obtained will be developed. The main objective of the project is to create and implement effective solutions that are an innovation on a global scale in the field of phospholipids, with optimal parameters for the creation of nanoagregates for the directed supply of medicines, supplements and medical devices. Specific objectives: development of an innovative composition and method of production of phospholipids guaranteeing nanostructures, including low-energy emergency processes; the identification of key lecithin parameters determining the stability of nano-aggregates will be investigated primarily for rape-lacytin, which is ideal for this type of application; introduction of solutions’ not available for competition (development of a unique process of producing lipid aggregates with specified parameters based on the non-genetically modified rapeseed produced in Poland). The project consists of 4 stages of industrial research and 2 stages of development. As a result, the following will be created: phospholipid composition optimal for the production of self-organised lipid structures with specified parameters development of a method of purification of lecithins for obtaining phospholipids optimal for liposome formation; determination of toxicity and efficacy profiles (English)
14 October 2020
0 references
Identifiers
POIR.04.01.04-00-0159/17
0 references